VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+4.9%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$265M
AUM Growth
+$37.5M
(+17%)
Cap. Flow
+$31.7M
Cap. Flow
% of AUM
11.98%
Top 10 Holdings %
Top 10 Hldgs %
9.25%
Holding
421
New
24
Increased
206
Reduced
145
Closed
45
Top Buys
| 1 |
DT Midstream
DTM
|
$1.86M |
| 2 |
ScottsMiracle-Gro
SMG
|
$878K |
| 3 |
Valero Energy
VLO
|
$790K |
| 4 |
FMC
FMC
|
$775K |
| 5 |
Delek US
DK
|
$761K |
Top Sells
| 1 |
COR
Coresite Realty Corporation
COR
|
$1.67M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$601K |
| 3 |
VTA
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
|
$551K |
| 4 |
Travere Therapeutics
TVTX
|
$479K |
| 5 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$448K |
Sector Composition
| 1 | Real Estate | 22.39% |
| 2 | Healthcare | 18.38% |
| 3 | Energy | 15.88% |
| 4 | Materials | 14.07% |
| 5 | Utilities | 13.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRW
176
Saba Capital Income & Opportunities Fund
BRW
$349M
| $367K | 0.14% |
40,597
-2,501
| -6% | -$22.6K |
|
177
Capital Southwest
CSWC
$1.28B
| $367K | 0.14% |
14,519
-9,342
| -39% | -$236K |
|
178
Ascendis Pharma
ASND
$12.5B
| $366K | 0.14% |
2,722
+1,141
| +72% | +$153K |
|
179
Vanda Pharmaceuticals
VNDA
$272M
| $366K | 0.14% |
23,335
-358
| -2% | -$5.62K |
|
|
ONC
180
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $362K | 0.14% |
1,336
+8
| +0.6% | +$2.17K |
|
181
Kiniksa Pharmaceuticals
KNSA
$2.65B
| $353K | 0.13% |
30,021
+12
| +0% | +$141 |
|
182
Regeneron Pharmaceuticals
REGN
$60.8B
| $350K | 0.13% |
554
-307
| -36% | -$194K |
|
183
BioNTech
BNTX
$27B
| $346K | 0.13% |
1,344
-729
| -35% | -$188K |
|
184
Moderna
MRNA
$9.78B
| $341K | 0.13% |
1,342
-866
| -39% | -$220K |
|
185
Alnylam Pharmaceuticals
ALNY
$59.2B
| $340K | 0.13% |
2,003
-742
| -27% | -$126K |
|
|
TSVT
186
DELISTED
2seventy bio
TSVT
| $337K | 0.13% |
+13,134
| New | +$337K |
|
187
Gladstone Investment Corp
GAIN
$543M
| $336K | 0.13% |
19,668
-13,470
| -41% | -$230K |
|
188
Crescent Capital BDC
CCAP
$591M
| $328K | 0.12% |
18,653
+1,651
| +10% | +$29K |
|
189
Main Street Capital
MAIN
$5.95B
| $327K | 0.12% |
7,297
-3,346
| -31% | -$150K |
|
|
BCIC
190
BCP Investment Corporation Common Stock
BCIC
$160M
| $295K | 0.11% |
11,905
-2,154
| -15% | -$53.4K |
|
191
OFS Capital
OFS
$117M
| $285K | 0.11% |
26,142
-6,944
| -21% | -$75.7K |
|
192
Oxford Square Capital
OXSQ
$172M
| $282K | 0.11% |
69,162
-8,860
| -11% | -$36.1K |
|
|
FCRD
193
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $276K | 0.1% |
61,721
-10,730
| -15% | -$48K |
|
194
Arcutis Biotherapeutics
ARQT
$2.06B
| $227K | 0.09% |
10,965
+3,661
| +50% | +$75.8K |
|
195
Kezar Life Sciences
KZR
$29.8M
| $222K | 0.08% |
+1,329
| New | +$222K |
|
196
Stoke Therapeutics
STOK
$1.13B
| $218K | 0.08% |
9,070
+3,568
| +65% | +$85.8K |
|
|
IMGO
197
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $215K | 0.08% |
+9,065
| New | +$215K |
|
198
Invesco Senior Loan ETF
BKLN
$6.98B
| $214K | 0.08% |
+9,683
| New | +$214K |
|
199
Arvinas
ARVN
$575M
| $205K | 0.08% |
2,494
-36
| -1% | -$2.96K |
|
|
ITOS
200
DELISTED
iTeos Therapeutics
ITOS
| $205K | 0.08% |
4,412
-3,319
| -43% | -$154K |
|